Global Nicotinamide Riboside (NR) Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Nicotinamide Riboside (NR) Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

According to APO Research, The global Nicotinamide Riboside (NR) market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Nicotinamide Riboside (NR) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Nicotinamide Riboside (NR) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Nicotinamide Riboside (NR) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Nicotinamide Riboside (NR) include ChromaDex, Genex Formulas, Bontac, Tiantai Biotechnology, Zhejiang Jiahua, Shandong Tianming Pharmaceutical, Suzhou MyLand Pharm & Nutrition, EnzymeWorks and Longer Livetech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nicotinamide Riboside (NR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Riboside (NR).

The Nicotinamide Riboside (NR) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nicotinamide Riboside (NR) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

ChromaDex
Genex Formulas
Bontac
Tiantai Biotechnology
Zhejiang Jiahua
Shandong Tianming Pharmaceutical
Suzhou MyLand Pharm & Nutrition
EnzymeWorks
Longer Livetech
Shenzhen Ejion Biotechnology

Nicotinamide Riboside (NR) segment by Type

Purity ≤98%
Purity >98%

Nicotinamide Riboside (NR) segment by Application

Health Supplement
Pharmaceutical Additives

Nicotinamide Riboside (NR) Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Riboside (NR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Riboside (NR) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Riboside (NR).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nicotinamide Riboside (NR) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Nicotinamide Riboside (NR) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Nicotinamide Riboside (NR) Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Nicotinamide Riboside (NR) Sales Estimates and Forecasts (2019-2030)
1.3 Nicotinamide Riboside (NR) Market by Type
1.3.1 Purity ≤98%
1.3.2 Purity >98%
1.4 Global Nicotinamide Riboside (NR) Market Size by Type
1.4.1 Global Nicotinamide Riboside (NR) Market Size Overview by Type (2019-2030)
1.4.2 Global Nicotinamide Riboside (NR) Historic Market Size Review by Type (2019-2024)
1.4.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Nicotinamide Riboside (NR) Sales Breakdown by Type (2019-2024)
1.5.2 Europe Nicotinamide Riboside (NR) Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Nicotinamide Riboside (NR) Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Nicotinamide Riboside (NR) Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Nicotinamide Riboside (NR) Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Nicotinamide Riboside (NR) Industry Trends
2.2 Nicotinamide Riboside (NR) Industry Drivers
2.3 Nicotinamide Riboside (NR) Industry Opportunities and Challenges
2.4 Nicotinamide Riboside (NR) Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Nicotinamide Riboside (NR) Revenue (2019-2024)
3.2 Global Top Players by Nicotinamide Riboside (NR) Sales (2019-2024)
3.3 Global Top Players by Nicotinamide Riboside (NR) Price (2019-2024)
3.4 Global Nicotinamide Riboside (NR) Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Nicotinamide Riboside (NR) Key Company Manufacturing Sites & Headquarters
3.6 Global Nicotinamide Riboside (NR) Company, Product Type & Application
3.7 Global Nicotinamide Riboside (NR) Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Nicotinamide Riboside (NR) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Nicotinamide Riboside (NR) Players Market Share by Revenue in 2023
3.8.3 2023 Nicotinamide Riboside (NR) Tier 1, Tier 2, and Tier 3
4 Nicotinamide Riboside (NR) Regional Status and Outlook
4.1 Global Nicotinamide Riboside (NR) Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Nicotinamide Riboside (NR) Historic Market Size by Region
4.2.1 Global Nicotinamide Riboside (NR) Sales in Volume by Region (2019-2024)
4.2.2 Global Nicotinamide Riboside (NR) Sales in Value by Region (2019-2024)
4.2.3 Global Nicotinamide Riboside (NR) Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Region
4.3.1 Global Nicotinamide Riboside (NR) Sales in Volume by Region (2025-2030)
4.3.2 Global Nicotinamide Riboside (NR) Sales in Value by Region (2025-2030)
4.3.3 Global Nicotinamide Riboside (NR) Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Nicotinamide Riboside (NR) by Application
5.1 Nicotinamide Riboside (NR) Market by Application
5.1.1 Health Supplement
5.1.2 Pharmaceutical Additives
5.2 Global Nicotinamide Riboside (NR) Market Size by Application
5.2.1 Global Nicotinamide Riboside (NR) Market Size Overview by Application (2019-2030)
5.2.2 Global Nicotinamide Riboside (NR) Historic Market Size Review by Application (2019-2024)
5.2.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Nicotinamide Riboside (NR) Sales Breakdown by Application (2019-2024)
5.3.2 Europe Nicotinamide Riboside (NR) Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Nicotinamide Riboside (NR) Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Nicotinamide Riboside (NR) Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Nicotinamide Riboside (NR) Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 ChromaDex
6.1.1 ChromaDex Comapny Information
6.1.2 ChromaDex Business Overview
6.1.3 ChromaDex Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ChromaDex Nicotinamide Riboside (NR) Product Portfolio
6.1.5 ChromaDex Recent Developments
6.2 Genex Formulas
6.2.1 Genex Formulas Comapny Information
6.2.2 Genex Formulas Business Overview
6.2.3 Genex Formulas Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Genex Formulas Nicotinamide Riboside (NR) Product Portfolio
6.2.5 Genex Formulas Recent Developments
6.3 Bontac
6.3.1 Bontac Comapny Information
6.3.2 Bontac Business Overview
6.3.3 Bontac Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bontac Nicotinamide Riboside (NR) Product Portfolio
6.3.5 Bontac Recent Developments
6.4 Tiantai Biotechnology
6.4.1 Tiantai Biotechnology Comapny Information
6.4.2 Tiantai Biotechnology Business Overview
6.4.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tiantai Biotechnology Nicotinamide Riboside (NR) Product Portfolio
6.4.5 Tiantai Biotechnology Recent Developments
6.5 Zhejiang Jiahua
6.5.1 Zhejiang Jiahua Comapny Information
6.5.2 Zhejiang Jiahua Business Overview
6.5.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zhejiang Jiahua Nicotinamide Riboside (NR) Product Portfolio
6.5.5 Zhejiang Jiahua Recent Developments
6.6 Shandong Tianming Pharmaceutical
6.6.1 Shandong Tianming Pharmaceutical Comapny Information
6.6.2 Shandong Tianming Pharmaceutical Business Overview
6.6.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product Portfolio
6.6.5 Shandong Tianming Pharmaceutical Recent Developments
6.7 Suzhou MyLand Pharm & Nutrition
6.7.1 Suzhou MyLand Pharm & Nutrition Comapny Information
6.7.2 Suzhou MyLand Pharm & Nutrition Business Overview
6.7.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product Portfolio
6.7.5 Suzhou MyLand Pharm & Nutrition Recent Developments
6.8 EnzymeWorks
6.8.1 EnzymeWorks Comapny Information
6.8.2 EnzymeWorks Business Overview
6.8.3 EnzymeWorks Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 EnzymeWorks Nicotinamide Riboside (NR) Product Portfolio
6.8.5 EnzymeWorks Recent Developments
6.9 Longer Livetech
6.9.1 Longer Livetech Comapny Information
6.9.2 Longer Livetech Business Overview
6.9.3 Longer Livetech Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Longer Livetech Nicotinamide Riboside (NR) Product Portfolio
6.9.5 Longer Livetech Recent Developments
6.10 Shenzhen Ejion Biotechnology
6.10.1 Shenzhen Ejion Biotechnology Comapny Information
6.10.2 Shenzhen Ejion Biotechnology Business Overview
6.10.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product Portfolio
6.10.5 Shenzhen Ejion Biotechnology Recent Developments
7 North America by Country
7.1 North America Nicotinamide Riboside (NR) Sales by Country
7.1.1 North America Nicotinamide Riboside (NR) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Nicotinamide Riboside (NR) Sales by Country (2019-2024)
7.1.3 North America Nicotinamide Riboside (NR) Sales Forecast by Country (2025-2030)
7.2 North America Nicotinamide Riboside (NR) Market Size by Country
7.2.1 North America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Nicotinamide Riboside (NR) Market Size by Country (2019-2024)
7.2.3 North America Nicotinamide Riboside (NR) Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Nicotinamide Riboside (NR) Sales by Country
8.1.1 Europe Nicotinamide Riboside (NR) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Nicotinamide Riboside (NR) Sales by Country (2019-2024)
8.1.3 Europe Nicotinamide Riboside (NR) Sales Forecast by Country (2025-2030)
8.2 Europe Nicotinamide Riboside (NR) Market Size by Country
8.2.1 Europe Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Nicotinamide Riboside (NR) Market Size by Country (2019-2024)
8.2.3 Europe Nicotinamide Riboside (NR) Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Nicotinamide Riboside (NR) Sales by Country
9.1.1 Asia-Pacific Nicotinamide Riboside (NR) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Nicotinamide Riboside (NR) Sales by Country (2019-2024)
9.1.3 Asia-Pacific Nicotinamide Riboside (NR) Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Nicotinamide Riboside (NR) Market Size by Country
9.2.1 Asia-Pacific Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Nicotinamide Riboside (NR) Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Nicotinamide Riboside (NR) Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Nicotinamide Riboside (NR) Sales by Country
10.1.1 Latin America Nicotinamide Riboside (NR) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Nicotinamide Riboside (NR) Sales by Country (2019-2024)
10.1.3 Latin America Nicotinamide Riboside (NR) Sales Forecast by Country (2025-2030)
10.2 Latin America Nicotinamide Riboside (NR) Market Size by Country
10.2.1 Latin America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Nicotinamide Riboside (NR) Market Size by Country (2019-2024)
10.2.3 Latin America Nicotinamide Riboside (NR) Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Nicotinamide Riboside (NR) Sales by Country
11.1.1 Middle East and Africa Nicotinamide Riboside (NR) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Nicotinamide Riboside (NR) Sales by Country (2019-2024)
11.1.3 Middle East and Africa Nicotinamide Riboside (NR) Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Nicotinamide Riboside (NR) Market Size by Country
11.2.1 Middle East and Africa Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Nicotinamide Riboside (NR) Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Nicotinamide Riboside (NR) Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Nicotinamide Riboside (NR) Value Chain Analysis
12.1.1 Nicotinamide Riboside (NR) Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Nicotinamide Riboside (NR) Production Mode & Process
12.2 Nicotinamide Riboside (NR) Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Nicotinamide Riboside (NR) Distributors
12.2.3 Nicotinamide Riboside (NR) Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings